State Of Wisconsin Investment Board Cti Biopharma Corp Transaction History

State Of Wisconsin Investment Board

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$4.2 - $6.01 $8,269 - $11,833	1,969 Added 2.15%	93,683 $393,000
Q4 2022 Feb 14, 2023	BUY	$4.45 - $6.17 $408,127 - $565,875	91,714 New	91,714 $551,000
Q2 2019 Aug 14, 2019	SELL	$0.8 - $1.03 $54,720 - $70,452	-68,400 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$0.9 - $1.37 $14,130 - $21,509	15,700 Added 29.79%	68,400 $66,000
Q4 2018 Feb 11, 2019	BUY	$0.73 - $2.19 $38,471 - $115,413	52,700 New	52,700 $39,000

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.